novo nordisk cuts prices for its glp-1 drugs. as Trump administration pushes cheaper GLP-1s The GLP-1 weight loss drug

Mol Metab 2013;3:24151.ArticlePubMedPMC 43

For detailed comparison of these medication options, see our Zepbound vs Wegovy guide

doi: 10.1016/j.molmet.2022.101533, 50

Among employers covering GLP-1 agonist drugs for weight loss, most firms view it as important or very important for employee satisfaction The meaningful shares of larger employers covering these medications for weight loss, notwithstanding their relatively high cost, underscores the importance many employers place on covering these medications for employees

Whether GIP-based co-agonists can provide greater maximal clinical efficacy, relative to optimized GLP-1R agonists remains unknown, and may be further evaluated in Phase 3 studies